Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Lamisil® (terbinafine) – New Warning
January 19, 2017 – The FDA approved a new update to the Warnings and Precautions section of the Lamisil (terbinafine) tablet and Lamisil oral granule drug labels regarding thrombotic microangiopathy (TMA).
